Optimized J to T peak and T peak to T end measurements in nonclinical species administered moxifloxacin and amiodarone.

Autor: Bartko TM; Labcorp Early Development Laboratories Inc., Madison, WI, United States of America. Electronic address: theresa.bartko@labcorp.com., Lutgen SM; Labcorp Early Development Laboratories Inc., Madison, WI, United States of America., Ross RA; Labcorp Early Development Laboratories Inc., Madison, WI, United States of America., Walisser JA; Labcorp Early Development Laboratories Inc., Madison, WI, United States of America., Garske EP; Labcorp Early Development Laboratories Inc., Madison, WI, United States of America., Kopelke KR; Labcorp Early Development Laboratories Inc., Madison, WI, United States of America., Ashcroft-Hawley K; Labcorp Early Development Laboratories Ltd., Harrogate, UK., Tang HM; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States of America., Kremer JJ; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States of America., Friedrichs GS; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States of America., Nichols JV; Labcorp Early Development Laboratories Inc., Madison, WI, United States of America.

Publikováno v: Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2024 Jul-Aug; Vol. 128, pp. 107527. Date of Electronic Publication: 2024 Jun 08.